Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

XEP:GR

50.300 EUR 2.061 3.94%

As of 13:01:49 ET on 02/27/2015.

Snapshot for Cepheid (XEP)

Open: 51.567 Day's Range: 50.300 - 52.410 Volume: 25
Previous Close: 52.361 52wk Range: 27.855 - 52.410 1-Yr Rtn: +27.95%

Stock Chart for XEP

No chart data available.
  • XEP:GR 51.634
  • 1D
  • 1M
  • 1Y
52.361
Interactive XEP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XEP

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.0270
Est. PEG Ratio -
Market Cap (M EUR) 3,584.95
Shares Outstanding (M) 71.27
30 Day Average Volume 1
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XEP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XEP

Cepheid, Inc. is a molecular diagnostics company dedicated to improving healthcare with its molecular systems and tests. The Company enables institutions to access the full power of molecular diagnostics with genetic testing for organisms and genetic-based diseases.

John L BishopChairman/CEOPhilippe JaconPresident:High Burden Dev
Warren C Kocmond JrExecutive VP/COODavid H PersingExec VP/Chief Medical & Tech Ofcr
More Company Profile & Key Executives for XEP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil